Post-Conference Report
This report provides a comprehensive guide to cancer vaccine-related abstracts from the annual meeting, featuring an analysis and detailed summaries. It analyses the distribution of abstracts by therapeutic class, antigen class and trial phase.
There are summaries of all preclinical and clinical abstracts, as well as trial outlines. These are organized by trial sponsor, abstract ID, trial ID, disease indication, target, and phase. Additionally, it includes information on dosing/description and safety results.
We are confident this will be an invaluable resource for understanding the latest advancements in the cancer vaccine field.
Beacon Cancer Vaccine
How the most complete cancer vaccine database can help you
What we cover
Beacon Cancer Vaccine covers trial and drug records for clinical, preclinical, approved and discontinued prophylactic and therapeutic cancer vaccines. This database will cover ‘off the shelf’ and personalized approaches to:
- Cellular Vaccines
- Viral Vaccines
- Bacterial Vaccines
- Protein Vaccines
- Yeast Vaccines
- Peptide Vaccines
- Nucleic Acid-Based Vaccines
New data expansion: Deals and Companies. Gain unparalleled access to in-depth company profiles and the latest commercial deals. Monitor your competitors and opportunities as well as benchmark deals and evaluate potential partners. Learn more about Deals and Companies data by downloading the factsheet.
How Beacon Cancer Vaccine works
Search the trial and drug landscape by antigen, vaccine type and adjuvant alongside other search criteria including disease, biomarker and sponsor to instantly extract the data points you need to conduct more complex analyses.
Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the cancer vaccine space.
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
At Beacon, we are committed to empowering our pharmaceutical and biotech industry partners with accurate, comprehensive data. We are not just a tool; we see ourselves as a partner in the drug development journey. Contact us to learn how we help you.
